Abstract: An automatic dishwashing detergent water-soluble pouch includes a water-soluble film that forms at least two separate chambers that are enclosed by water-soluble film. The separate chambers include a first chamber and a second chamber. The first chamber is connected to the second chamber by a linking portion of water-soluble film, and a length of the linking portion of water-soluble film between the first chamber and second chamber is at least 1.2 cm. The first and second chambers include detergent ingredients.

Abstract: This disclosure is directed towards a patient management system for selectively storing and/or sharing patient data. A wearable device may sense a condition associated with the wearer of the wearable device, and store values based on the condition for a period of time. The wearable device may determine that the wearable device is within range of another device, such that the wearable device can communicate with the other device, and output the values to the other device. Additionally, a computing device of the patient management system may receive, from a wearable device, first data associated with a condition of a wearer of the wearable device. The computing device may also receive second data associated with the condition from a sensing device. The computing device may determine a context of the wearer based on comparing the first and second data, and control output of an alert based on the context.

Abstract: This document provides methods and materials involved in assessing samples (e.g., cancer cells) for the presence of a loss of heterozygosity (LOH) signature. For example, methods and materials for determining whether or not a cell (e.g., a cancer cell) contains an LOH signature are provided. Materials and methods for identifying cells (e.g., cancer cells) having a deficiency in homology directed repair (HDR) as well as materials and methods for identifying cancer patients likely to respond to a particular cancer treatment regimen also are provided.

Abstract: Examples described herein relate to transitioning a playback session between portable playback devices such as “smart” headphones, earbuds, and handheld speakers with playback devices of a zone-based media playback system. Exemplary techniques facilitate continuity of playback when transitioning between locations (e.g., from at home to on-the-go or vice versa) or between listening paradigms (e.g., personal or out-loud playback of audio content). An example implementation includes detecting a swap trigger, determining the source playback device(s) and target playback device(s), and performing a playback session swap between the source playback device(s) and target playback device(s).

Abstract: Systems and methods for dynamically routing a customer request to various representatives are disclosed. In some embodiments, a disclosed method includes: obtaining, from a customer, a request for service from an entity; obtaining context information of the request; selecting, from a set of representatives associated with the entity, a dynamic target group of representatives based on the context information and a predetermined set of criteria; and routing the request simultaneously to agent devices associated with the dynamic target group of representatives.

Abstract: Examples described herein relate to transitioning a playback session between portable playback devices such as “smart” headphones, earbuds, and handheld speakers with playback devices of a zone-based media playback system. Exemplary techniques facilitate continuity of playback when transitioning between locations (e.g., from at home to on-the-go or vice versa) or between listening paradigms (e.g., personal or out-loud playback of audio content). An example implementation includes detecting a swap trigger, determining the source playback device(s) and target playback device(s), and performing a playback session swap between the source playback device(s) and target playback device(s).

Abstract: A medical system includes a computing system, and a connection device having a lifetime and including first and second connectors connectable to the computing system and one or more medical devices, respectively. The computing system is configured to perform operations to independently monitor usage of the first and second connectors, including: detecting a connection of the first and second connectors to the computing system and a first medical device, respectively; receiving usage information of the first and second connectors; updating the usage information based on the connection of the first and second connectors to the computing system and the first medical device, respectively; and in response to determining at least one of a plurality of predetermined thresholds specific to each of the first and second connectors and indicating the lifetime of the connection device is approaching or has been reached, has been met or exceeded, performing one or more actions.

Abstract: A method for identifying hazards in a robot application comprises a) providing a model of an application environment of a robot, the application environment extending beyond the limits of a movement range of the robot, the movement range comprising all points that the robot can occupy in any pose it is capable of assuming; b) identifying at least one point in the environment suitable for supporting a person; c) for each point identified in step b), defining a safety space above the point, the safety space comprising a volume expected to be occupied by a person supported by the point and a safety range around the volume; d) identifying one of the at least one point identified in step b) as hazardous when the safety space associated to said point overlaps with the movement range of the robot.

Abstract: Provided herein are methods to identify immunogenic G. Parasuis proteins, compositions comprising such immunogenic proteins, kits comprising such immunogenic proteins, and methods of using such immunogenic proteins to prevent G. Parasuis in pigs.

Abstract: The coating can have a low-sweetness perception. During manufacturing and processing, the coating maintains a flowability to allow a glaze state of the coating to be applied to a food. Upon cooling, the glaze state of the coating forms a glass state that provides a low-sweetness impact which facilitates application of savory taste perceptions.

Abstract: An electrical circuit, having: an oscillating element configured to provide a clock signal; and a clock synchronization unit configured to adapt the clock signal based on a reference signal; wherein the clock synchronization unit is configured to extract from an alternating signal the reference signal.

Abstract: A material includes an implantable substrate defined by at least one inelastic filament, wherein the implantable substrate is porous and includes recoverable stored length when free of elastomeric materials. The at least one inelastic filament is bioabsorbable.

Abstract: This document provides methods and materials involved in assessing samples (e.g., cancer cells) for the presence of homologous recombination deficiency (HRD) or an HRD signature. For example, methods and materials for determining whether or not a cell (e.g., a cancer cell) contains an HRD signature are provided. Materials and methods for identifying cells (e.g., cancer cells) having a deficiency in homology directed repair (HDR) as well as materials and methods for identifying cancer patients likely to respond to a particular cancer treatment regimen also are provided.

Abstract: A patient support apparatus includes a base frame, lift mechanism supporting an upper frame relative to the base frame, a load frame, and a plurality of deck sections, a patient support surface, and a number of barriers positioned about the patient supporting surface. The patient support apparatus includes a notification system for visually notifying a caregiver of a condition or status of a component of the patient support apparatus.

Abstract: This document provides methods and materials involved in assessing samples (e.g., cancer cells) for the presence of a loss of heterozygosity (LOH) signature. For example, methods and materials for determining whether or not a cell (e.g., a cancer cell) contains an LOH signature are provided. Materials and methods for identifying cells (e.g., cancer cells) having a deficiency in homology directed repair (HDR) as well as materials and methods for identifying cancer patients likely to respond to a particular cancer treatment regimen also are provided.

Abstract: A CRISPR-Cas9 system for treating a disease, disorder, or condition associated with one or more somatic mutations in a subject in need of treatment thereof is disclosed. The system comprises a sgRNA-guided Cas9, wherein the sgRNA targets between about 1 to about 50 mutations in a target cell. The CRISPR-Cas9 system can be used to treat diseases, disorders, or conditions associated with one or more somatic mutations, including cancers, autoimmune diseases, and/or neurodegenerative diseases. Additionally, the present disclosure relates to methods of identifying somatic mutations in a tumor that produce a protospacer adjacent motif (PAM) and methods of designing a CRISPR-Cas 9 system to target PAMs identified in a tumor sample obtained from a subject.

Abstract: A method of generating a color image using a monochromatic image sensor. The method includes sequentially illuminating a surface in a plurality of colors, one color at a time. The monochromatic image sensor captures a plurality of image frames of the surface based on the plurality of colors. The plurality of image frames are identified, and at least one feature in the target of the plurality of image frames is highlighted. Color intensities of the plurality of image frames are normalized. A color intensity map of the target for each of the plurality of image frames is generated. A correlation score is determined by comparing each color intensity map of the plurality of image frames. The color image is generated based on the correlation score.

Abstract: A security platform of a data network is provided that includes security services for computing devices in communication with the data network. The security platform may apply a security policy to the computing devices when accessing the Internet via a home network (or other customer network) and when accessing the Internet via a public or third party network. To provide security services to computing devices via the home network, the security platform may communicate with a security agent application executed on the router (or other gateway device) of the home network. In addition, each of the devices identified by the security profile for the home network may be instructed or otherwise be provided a security agent application for execution on the computing devices. The security agent application may communicate with the security platform when the computing device connects to the Internet over a third party or public access point.

Abstract: Crosslinkable compositions are developed based on an elastomer-containing powder or pelletized material, for instance composed of recycled material such as used tyres, including specific additives, and to elastomer compounds and articles obtainable therefrom, and to methods for the production thereof. The crosslinkable composition includes (a) a powder or pelletized material including at least one elastomer, (b) at least one poly-C5-C15-alkenamer, (c) at least one liquid poly butadiene, and (d) at least one crosslinking agent.

Abstract: A medical device that includes a handle, a shaft extending from the handle, and an assembly coupled to a distal end of the shaft. The assembly includes an end cap including first and second channels, an imaging mechanism coupled to the end cap and received within the first channel, and a lighting mechanism coupled to the end cap and received within the second channel. The assembly includes a first circuit assembly coupled to the end cap and a second circuit assembly coupled to the first circuit assembly. The imaging and lighting mechanisms are mounted onto the first circuit assembly. The first circuit assembly includes a rigid circuit board communicatively coupled to the imaging and lighting mechanisms. The second circuit assembly includes a flexible circuit board interposed between and communicatively coupled to the first circuit assembly and a control system of the medical device.